IQ-AI, Ltd.

IQ-AI, Ltd.

  • News & Announcements
  • Shareholder Information
  • Investor Relations
  • Significant Shareholders
  • Publications
  • Home
  • Corporate News & Announcements
  • IQ-AI News & Announcements
  • Result of Broker Option and Total Voting Rights

Result of Broker Option and Total Voting Rights

Monday, 26 February 2024 / Published in IQ-AI News & Announcements

Result of Broker Option and Total Voting Rights

/**/
RNS Number : 3536E
IQ-AI Limited
26 February 2024
 

IQ-AI Limited

(“IQ-AI” or the “Company”)

Result of Broker Option and Total Voting Rights

 

IQAI Limited (the “Company” or “IQAI”), is pleased to announce the result of the Broker Option that was announced on 22 February 2024 alongside a £300,000 placing.

 

The Company’s broker, Peterhouse Capital Limited (“Peterhouse”), has informed the Company that it has exercised its Broker Option in respect of 4,733,333 new ordinary shares of £0.01 each in the Company (“Ordinary Shares”) (together the “Broker Option Shares”).

 

The Broker Option Shares will be issued at £0.015 per new Ordinary Share (the “Issue Price”), resulting in gross proceeds of £71,000 being raised. Related to this and as announced on 22 February 2024, £300,000 has been raised by the Company through the issue of 20,000,000 new Ordinary Shares (the “Placing Shares”) at the Issue Price (the “Placing” and together with the Broker Option, the “Fundraise”). This brings the total amount raised under the Fundraise to £371,000 (before expenses).

 

Admission to trading

 

An application will be made for the 20,000,000 Placing Shares and the 4,733,333 Broker Option Shares to the Official List of the UK Listing Authority by way of a Standard Listing (“Admission”) and it is expected that Admission will become effective and that dealing in the Placing Shares and the Broker Option Shares will commence on or around 8am on or around 1 March 2024. The Placing Shares and Broker Option Shares will rank pari passu with the Company’s existing Ordinary Shares.

 

Total voting rights

 

Following Admission, the Company’s enlarged issued share capital will be 221,709,789 Ordinary Shares. The Company holds no Ordinary Shares in Treasury. This figure of 221,709,789 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

**ENDS**

 For further information please contact:

 

IQ-AI Limited

Trevor Brown/Brett Skelly/Vinod Kaushal

Tel: 020 7469 0930

 

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797                

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Article source

Recent Posts

  • Application: FDA Breakthrough Therapy Designation

    /**/ RNS Number : 2234H IQ-AI Limited 02 May 20...
  • Notice of AGM

    /**/ RNS Number : 6338G IQ-AI Limited 29 April ...
  • Publication of Annual Report

    /**/ RNS Number : 2817G IQ-AI Limited 25 April ...
  • Promising Preliminary Results of Phase 1 Study

    /**/ RNS Number : 7655E IQ-AI Limited 11 April ...
  • Placing to raise £250,000

    /**/ RNS Number : 1361B IQ-AI Limited 18 March ...
  • Policies
  • Investor Information

iq-ai@imagingbiometrics.com

IFC5
St Helier, Jersey, Channel Islands
JE1 1ST

Copyright © 2015-2025 IQ-AI Ltd. All Rights Reserved. IQ-AI is a trademark of IQ-AI Ltd.
TOP
Our website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptReject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT